BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 22876029)

  • 1. Crucial steps in the natural history of inflammatory bowel disease.
    Latella G; Papi C
    World J Gastroenterol; 2012 Aug; 18(29):3790-9. PubMed ID: 22876029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, serological and genetic predictors of inflammatory bowel disease course.
    Beaugerie L; Sokol H
    World J Gastroenterol; 2012 Aug; 18(29):3806-13. PubMed ID: 22876031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of medical therapies on inflammatory bowel disease complication rate.
    Reenaers C; Belaiche J; Louis E
    World J Gastroenterol; 2012 Aug; 18(29):3823-7. PubMed ID: 22876033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of inflammatory bowel disease.
    Burisch J; Munkholm P
    Scand J Gastroenterol; 2015 Aug; 50(8):942-51. PubMed ID: 25687629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease. Part I: Nature and pathogenesis.
    Kirsner JB
    Dis Mon; 1991 Oct; 37(10):605-66. PubMed ID: 1893828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
    Ochsenkühn T; Sackmann M; Göke B
    Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current therapeutic approaches in inflammatory bowel disease.
    Sohrabpour AA; Malekzadeh R; Keshavarzian A
    Curr Pharm Des; 2010; 16(33):3668-83. PubMed ID: 21128898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD.
    Le Berre C; Peyrin-Biroulet L;
    Gastroenterology; 2021 Apr; 160(5):1452-1460.e21. PubMed ID: 33421515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
    Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
    Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
    Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
    J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute idiopathic pancreatitis is associated with more aggressive disease course in Crohn's disease but not in ulcerative colitis.
    Osman KT; Hoque A; Pasam RT; Farhoud A; Abdelfattah A; Ramadorai V; Chaudrey K; Pellish R
    BMC Gastroenterol; 2023 May; 23(1):171. PubMed ID: 37217857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel disease. Part II: Clinical and therapeutic aspects.
    Kirsner JB
    Dis Mon; 1991 Nov; 37(11):669-746. PubMed ID: 1935537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent understanding of IBD pathogenesis: implications for future therapies.
    Kucharzik T; Maaser C; Lügering A; Kagnoff M; Mayer L; Targan S; Domschke W
    Inflamm Bowel Dis; 2006 Nov; 12(11):1068-83. PubMed ID: 17075348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer in inflammatory bowel disease: review of the evidence.
    Keller DS; Windsor A; Cohen R; Chand M
    Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease.
    Braga Neto MB; Gregory MH; Ramos GP; Bazerbachi F; Bruining DH; Abu Dayyeh BK; Kushnir VM; Raffals LE; Ciorba MA; Loftus EV; Deepak P
    Inflamm Bowel Dis; 2020 Jun; 26(7):1089-1097. PubMed ID: 31613968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental risk factors for inflammatory bowel disease.
    Singh N; Bernstein CN
    United European Gastroenterol J; 2022 Dec; 10(10):1047-1053. PubMed ID: 36262056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark.
    Jess T; Riis L; Vind I; Winther KV; Borg S; Binder V; Langholz E; Thomsen OØ; Munkholm P
    Inflamm Bowel Dis; 2007 Apr; 13(4):481-9. PubMed ID: 17206705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Search for Causative Environmental Factors in Inflammatory Bowel Disease.
    Rogler G; Zeitz J; Biedermann L
    Dig Dis; 2016; 34 Suppl 1():48-55. PubMed ID: 27548430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.